Aqur Biosciences
Aqur Biosciences, Inc.
Revolutionizing cardiovascular health with breakthrough science. At Aqur Biosciences, we are on a mission to redefine the future of cardiovascular health. Headquartered in Westlake Village, California, we are a pioneering bioscience company dedicated to developing cutting-edge treatments that push t
aqurbiosciences.com · Westlake Village, CA
Funding event
The round itself, as filedInferred stageSeed
Sold of offered$1.5M of $1.5M
Filed2026-09-18
Days since filing15
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- Yes
- Date of first sale
- 2026-09-03
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Michael A FoleExecutive Officer
- Jeffrey B WolinExecutive Officer · Director
- James Hess LeachExecutive Officer
- Michel F DenarieExecutive Officer
- Tomi K SawyerExecutive Officer
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged100% sold1 month since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-210
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-02, against 71 in the 28 days before.